Pharmaceuticals - Community Register


Community register of veterinary medicinal products


Product information

Invented name: Pexion   
Auth. number : EU/2/12/147
Active substance : Imepitoin
ATC: Anatomical main group: QN - Nervous system
Therapeutic subgroup: QN03 - Antiepileptics
Pharmacological subgroup: QN03A - Antiepileptics
Chemical subgroup: QN03AX - Other antiepileptics
Chemical substance: QN03AX90 - imepitoin
(See WHO ATCvet Index)
Indication: For the reduction of the frequency of generalised seizures due to idiopathic epilepsy in dogs for use after careful evaluation of alternative treatment options
Marketing Authorisation Holder: Boehringer Ingelheim Vetmedica GmbH
D-55216 Ingelheim am Rhein, Deutschland
EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
27/02/2013 Centralised - Authorisation EMEA/V/C/2543 (2013)1187 of 25/02/2013
3/01/2014 Centralised - Variation EMEA/V/C/2543/IB/3
Updated with Decision(2014)10097 of 16/12/2014
18/12/2014 Centralised - Yearly update (2014)10097 of 16/12/2014
10/04/2015 Centralised - Variation EMEA/V/C/2543/IB/5
Updated with Decision(2016)2429 of 18/04/2016
6/08/2015 Centralised - Variation EMEA/V/C/2543/IB/6
Updated with Decision(2016)2429 of 18/04/2016
9/12/2015 Centralised - Variation EMEA/V/C/2543/IB/7
Updated with Decision(2016)2429 of 18/04/2016
20/04/2016 Centralised - Yearly update (2016)2429 of 18/04/2016
27/09/2016 Centralised - Variation EMEA/V/C/2543/IG/722/8
Updated with Decision(2017)7432 of 31/10/2017
15/06/2017 Centralised - Variation EMEA/V/C/2543/II/9
Updated with Decision(2017)7432 of 31/10/2017
6/11/2017 Centralised - Yearly update (2017)7432 of 31/10/2017
23/11/2017 Centralised - Renewal EMEA/V/C/2543/R/10 (2017)7895 of 21/11/2017
13/03/2018 Centralised - Variation EMEA/V/C/2543/IB/12